We are monitoring the impact of COVID-19 on HIV Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2043
Share on
Share on

Global HIV Diagnostics Market Analysis - By Product (Consumables (Assays and Kits &Reagents and Other Consumables), Instruments, Software and Services), By Type (Antibody Tests, Viral Identification Tests, CD4 Testing, Viral Load Testing, Early Infant Diagnostics), By End-Users (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings and Other End-Users), Region - Industry Size, Share, Trends, Growth Opportunities Assessment, Forecast | 2019 - 2024

Pulished: February, 2020
ID: 2043
Pages: 180

HIV Diagnostics Market Size & Growth (2019 - 2024)

The size of the Global HIV Diagnostics Market was worth USD 2.61 Billion in 2019 and is estimated to be growing at a CAGR of 9.5%, to reach USD 4.11 Billion by 2024 during the forecast period.

The human immunodeficiency virus (HIV) infection refers to a kind of retrovirus that causes (AIDS). HIV affects some immune cells, and it weakens the immune system bringing about loss of capacity to fight against the organisms that cause diseases. 

Industry Growth Drivers

  • The increasing population of people diagnosed with HIV
  • The rise in demand for the technologically advanced devices for diagnosing HIV with high accuracy
  • The growing adoption rate of home kits for diagnosis and testing of HIV
  • Increasing investments form private, and government organization for developing effective diagnostic techniques for treating HIV patients
  • The emergence of simple, rapid assays with visual testing better handling

Major Challenges

  • The inappropriate functioning of regulatory bodies with stringent rules
  • High costs associated with Nucleic acid testing (NAT) and advanced diagnostics of HIV
  • Lack of a proper regulatory framework for NAT in developing countries

Industry Overview

According to WHO, people diagnosing with HIV reaching millions, out of which few millions of people die every year. AIDS is the advance stage of HIV which affects the immune system. People whose CD4 cells are lower than 200/mm are diagnosing as AIDS patients. This HIV test uses samples of blood, serum or urine where blood samples give accurate diagnosis result.

In India, the AIDS control programme has got a success story. The FDA has accepted the test to diagnose the HIV Type1 drug resistance using NGS, i.e., next-generation sequencing. 

However, the governments across the world have conducted campaigns, educational seminars in colleges, corporate places, and other public places to bring awareness to people. Recently Kenya Medical Research Institute has introduced its new Cobas Plasma Separation Card to collect samples and to test them in a short period. 

Key Happenings in this Market in the Recent Past:

  • The scientist team of Abbott laboratories has discovered a new subtype of HIV called HIV-1 Group M, subtype L., the Abbott laboratories team, has announced the event of this new strain discovery in November 2019.   
  • Roche Company has announced that it is committed to expanding its Global Access program in developing and low economy countries to provide accessibility of cost-effective resources, to eliminate diseases in these regions where the prevalence of diseases is on a higher note.

  REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Product, Type, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This market research report on the Global HIV Diagnostics Market has been segmented and sub-segmented based on the product type, test type, end-user and region.

By Product

  • Consumables
    • Assays
    • Kits & Reagents
    • Others
  • Instruments
  • Software
  • Services

Based on the product, the consumables segment is contributing a significant share to the global HIV diagnostics market. Factors like the increasing incidence of HIV and AIDS as most of the hospitals and laboratories; governments of various countries have started working aggressively to control HIV/AIDS boosting the usage of consumables. 

By Test Type

  • Antibody Tests
    • HIV Screening Tests
      • Elisa
      • Rapid Tests
      • Home Access Dried Blood Spots
    • HIV-1 Antibody Confirmatory Tests
      • Western Blot Tests
      • Indirect Immunofluorescence Assays (IFA)
      • Line Immunoassays
      • Radio-Immunoprecipitation Assays
    • HIV-2 & Group O Diagnostic Tests
      • Blood Antibody Tests
      • DBS Tests
      • Line ImmunoAssay (HIV2)
  • Viral Identification Tests
    • p24 Antigen Test
    • Qualitative PCR Tests
    • Viral Culture
  • CD4 Testing
  • Viral load testing
  • Early Infant Diagnostics

Based on type, the Antibody tests segment is dominating the market growth and continue its trend during the forecast period. The factors that are contributing to the growth of this segment are increasing account of blood donations, raising awareness of HIV and Aids among people, the emergence of novel and innovative medical practices owing to technological advancements.  

By End-User

  • Diagnostic Laboratories
  • Hospitals
  • Blood Banks
  • Home Care Settings
  • Other End-Users

Based on end-user, the diagnostic laboratories segment is dominating the global HIV Diagnostics market owing to factors such as spreading awareness about HIV and AIDS among the people in developing countries. Further, the increasing focus of private and government organizations to incline investments in developing advanced diagnostic laboratories with technologically advanced equipment and diagnostic techniques.

Regional Analysis

The Global HIV Diagnostics Market was dominated by North America, with the overall market share of over 38% globally. North America was followed by Asia pacific. The Asia Pacific to grow at a rapid pace in the coming few years, because of its high unmet demand in India and China.

North America to dominate the HIV Diagnostics Market with the most significant shares. Rising incidences of various health diseases and growing demand for the development of novel drugs are significant factors propelling the application of the market in this region. Increasing awareness among people, government initiatives to prevent HIV, widening of research and development of health facilities are also the reason for the growth in the North America region.

Europe and Asia-Pacific regions are following North America and are likely to have the highest share during the period. Increase in disposable income and recently developed healthcare equipment to propel the demand of the market. Countries like India and China are playing significant roles in contributing the highest shares for the market.

The Middle East and Africa region are to have a slow-growth due to lack of knowledge among the people. In this region, South Africa has the highest HIV prevalent.

List of key market participants leading the Global HIV Diagnostics Market profiled in this report:

  1. Abbott Healthcare
  2. Alere Inc.
  3. Bristol-Myers Squibb
  4. Abbvie Inc.
  5. Gilead Sciences
  6. Janssen Therapeutics
  7. Merck & Co., Inc.
  8. BD Biosciences
  9. VIIV Healthcare
  10. Beckman Coulter
  11. Partec
  12. Sysmex
  13. Apogee Flow Systems
  14. Zyomyx Inc.
  15. Mylan Inc.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Consumables                         

                                                5.1.2.1 Assays and Kits &Reagents           

                                                5.1.2.2 Other Consumables        

                                5.1.3 Instruments                           

                                5.1.4 Software & Services                            

                                5.1.5  Y-o-Y Growth Analysis, By Product                              

                                5.1.6  Market Attractiveness Analysis, By Product                            

                                5.1.7  Market Share Analysis, By Product                              

                5.2 Type                                              

                                5.2.1 Introduction                           

                                5.2.2 Antibody Tests                      

                                                5.2.2.1 HIV Screening Tests         

                                                                5.2.2.1.1 Elisa

                                                                5.2.2.1.2 Rapid Tests

                                                                5.2.2.1.3 Home Access Dried Blood Spots

                                                5.2.2.2 HIV-1 Antibody Confirmatory Tests          

                                                                5.2.2.2.1 Western Blot Tests

                                                                5.2.2.2.2  Indirect Immunofluorescence Assays (IFA)

                                                                5.2.2.2.3 Line Immunoassays

                                                                5.2.2.2.4 Radio-Immunoprecipitation Assays

                                                5.2.2.3  HIV-2 & Group O Diagnostic Tests            

                                                                5.2.2.3.1 Blood Antibody Tests

                                                                5.2.2.3.2 DBS Tests

                                                                5.2.2.3.3 Line ImmunoAssay (HIV2)

                                5.2.3 Viral Identification Tests                    

                                                5.2.3.1 p24 Antigen Test               

                                                5.2.3.2 Qualitative PCR Tests      

                                                5.2.3.3 Viral Culture        

                                5.2.4 CD4 Testing                             

                                5.2.5 Viral Load testing                  

                                5.2.6 Early Infant Diagnostics                      

                                5.2.7 Y-o-Y Growth Analysis, By Type                     

                                5.2.8 Market Attractiveness Analysis, By Type                   

                                5.2.9 Market Share Analysis, By Type                     

                5.3 End User                                      

                                5.3.1 Introduction                           

                                5.3.2 Diagnostic Laboratories                     

                                5.3.3 Hospitals                  

                                5.3.4 Blood Banks                            

                                5.3.5 Home Care Settings                            

                                5.3.6 Other End Users                   

                                5.3.7 Y-o-Y Growth Analysis, By End User                             

                                5.3.8  Market Attractiveness Analysis, By End User                          

                                5.3.9  Market Share Analysis, By End User                            

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Type 

                                                6.1.3.4 By End User        

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Type 

                                                6.1.4.4 By End User        

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Type 

                                                6.1.5.4 By End User        

                6.2 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.3 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                            

                                6.2.6 France                       

                6.4 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                         

                                6.3.5 Australia                   

                                6.3.6 South Korea                           

                6.5 Latin America                                             

                                6.4.1 Introduction                           

                                6.4.2 Brazil                          

                                6.4.3 Argentina                

                                6.4.4 Mexico                     

                                6.4.5 Rest of Latin America                          

                6.6 Middle East & Africa                                               

                                6.5.1 Introduction                           

                                6.5.2 Middle-East                            

                                6.5.3 Africa                         

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Siemens Healthineers (A Division of Siemens AG)                                     

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Roche Diagnostics (Division of Hoffman La Roche Ltd.)                                            

                8.3 Abbott Laboratories                                               

                8.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)                                  

                8.5 Thermo-Fisher Scientific Inc.                                               

                8.6 Merck KGaA                                               

                8.7 Becton, Dickinson & Company                                           

                8.8 Hologic Inc.                                 

                8.9 Alere Inc.                                     

                8.10 Bio-Rad Laboratories                                            

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global HIV Diagnostics Market By Region, From 2019-2024 ( USD Million )
  2. Global HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  3. Global Consumables Market By Region, From2019-2024 ( USD Million )
  4. Global Instruments Market By Region, From2019-2024 ( USD Million )
  5. Global Software & Services Market By Region, From2019-2024 ( USD Million )
  6. Global HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  7. Global Antibody Tests Market By Region, From2019-2024 ( USD Million )
  8. Global Viral Identification tests Market By Region, From2019-2024 ( USD Million )
  9. Global CD4 Testing Market By Region, From2019-2024 ( USD Million )
  10. Global Viral Load Testing Market By Region, From2019-2024 ( USD Million )
  11. Global Early Infant Diagnosticss Market By Region, From2019-2024 ( USD Million )
  12. Global HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  13. Global Diagnostic Labortaries Market By Region, From2019-2024 ( USD Million )
  14. Global Hospitals Market By Region, From2019-2024 ( USD Million )
  15. Global Blood Banks Market By Region, From2019-2024 ( USD Million )
  16. Global Home Care Settings Market By Region, From2019-2024 ( USD Million )
  17. Global Other End Users Market By Region, From2019-2024 ( USD Million )
  18. North America HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  19. North America Consumables Market By Region, From2019-2024 ( USD Million )
  20. North America Instruments Market By Region, From2019-2024 ( USD Million )
  21. North America Software & Services Market By Region, From2019-2024 ( USD Million )
  22. North America HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  23. North America Antibody Tests Market By Region, From2019-2024 ( USD Million )
  24. North America Viral Identification tests Market By Region, From2019-2024 ( USD Million )
  25. North America CD4 Testing Market By Region, From2019-2024 ( USD Million )
  26. North America Viral Load Testing Market By Region, From2019-2024 ( USD Million )
  27. North America Early Infant Diagnosticss Market By Region, From2019-2024 ( USD Million )
  28. North America HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  29. North America Diagnostic Labortaries Market By Region, From2019-2024 ( USD Million )
  30. North America Hospitals Market By Region, From2019-2024 ( USD Million )
  31. North America Blood Banks Market By Region, From2019-2024 ( USD Million )
  32. North America Home Care Settings Market By Region, From2019-2024 ( USD Million )
  33. North America Other End Users Market By Region, From2019-2024 ( USD Million )
  34. United States HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  35. United States HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  36. United States HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  37. Canada HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  38. Canada HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  39. Canada HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  40. Europe HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  41. Europe Consumables Market By Region, From2019-2024 ( USD Million )
  42. Europe Instruments Market By Region, From2019-2024 ( USD Million )
  43. Europe Software & Services Market By Region, From2019-2024 ( USD Million )
  44. Europe HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  45. Europe Antibody Tests Market By Region, From2019-2024 ( USD Million )
  46. Europe Viral Identification tests Market By Region, From2019-2024 ( USD Million )
  47. Europe CD4 Testing Market By Region, From2019-2024 ( USD Million )
  48. Europe Viral Load Testing Market By Region, From2019-2024 ( USD Million )
  49. Europe Early Infant Diagnosticss Market By Region, From2019-2024 ( USD Million )
  50. Europe HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  51. Europe Diagnostic Labortaries Market By Region, From2019-2024 ( USD Million )
  52. Europe Hospitals Market By Region, From2019-2024 ( USD Million )
  53. Europe Blood Banks Market By Region, From2019-2024 ( USD Million )
  54. Europe Home Care Settings Market By Region, From2019-2024 ( USD Million )
  55. Europe Other End Users Market By Region, From2019-2024 ( USD Million )
  56. U.K. HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  57. U.K. HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  58. U.K. HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  59. Germany HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  60. Germany HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  61. Germany HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  62. France HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  63. France HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  64. France HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  65. Italy HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  66. Italy HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  67. Italy HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  68. Spain HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  69. Spain HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  70. Spain HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  71. Asia-Pacific HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  72. Asia-Pacific Consumables Market By Region, From2019-2024 ( USD Million )
  73. Asia-Pacific Instruments Market By Region, From2019-2024 ( USD Million )
  74. Asia-Pacific Software & Services Market By Region, From2019-2024 ( USD Million )
  75. Asia-Pacific HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  76. Asia-Pacific Antibody Tests Market By Region, From2019-2024 ( USD Million )
  77. Asia-Pacific Viral Identification tests Market By Region, From2019-2024 ( USD Million )
  78. Asia-Pacific CD4 Testing Market By Region, From2019-2024 ( USD Million )
  79. Asia-Pacific Viral Load Testing Market By Region, From2019-2024 ( USD Million )
  80. Asia-Pacific Early Infant Diagnosticss Market By Region, From2019-2024 ( USD Million )
  81. Asia-Pacific HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  82. Asia-Pacific Diagnostic Labortaries Market By Region, From2019-2024 ( USD Million )
  83. Asia-Pacific Hospitals Market By Region, From2019-2024 ( USD Million )
  84. Asia-Pacific Blood Banks Market By Region, From2019-2024 ( USD Million )
  85. Asia-Pacific Home Care Settings Market By Region, From2019-2024 ( USD Million )
  86. Asia-Pacific Other End Users Market By Region, From2019-2024 ( USD Million )
  87. Japan HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  88. Japan HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  89. Japan HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  90. China HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  91. China HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  92. China HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  93. India HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  94. India HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  95. India HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  96. Australia HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  97. Australia HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  98. Australia HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  99. South Korea HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  100. South Korea HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  101. South Korea HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  102. Latin America HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  103. Latin America Consumables Market By Region, From2019-2024 ( USD Million )
  104. Latin America Instruments Market By Region, From2019-2024 ( USD Million )
  105. Latin America Software & Services Market By Region, From2019-2024 ( USD Million )
  106. Latin America HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  107. Latin America Antibody Tests Market By Region, From2019-2024 ( USD Million )
  108. Latin America Viral Identification tests Market By Region, From2019-2024 ( USD Million )
  109. Latin America CD4 Testing Market By Region, From2019-2024 ( USD Million )
  110. Latin America Viral Load Testing Market By Region, From2019-2024 ( USD Million )
  111. Latin America Early Infant Diagnosticss Market By Region, From2019-2024 ( USD Million )
  112. Latin America HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  113. Latin America Diagnostic Labortaries Market By Region, From2019-2024 ( USD Million )
  114. Latin America Hospitals Market By Region, From2019-2024 ( USD Million )
  115. Latin America Blood Banks Market By Region, From2019-2024 ( USD Million )
  116. Latin America Home Care Settings Market By Region, From2019-2024 ( USD Million )
  117. Latin America Other End Users Market By Region, From2019-2024 ( USD Million )
  118. Brazil HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  119. Brazil HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  120. Brazil HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  121. Argentina HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  122. Argentina HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  123. Argentina HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  124. Mexico HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  125. Mexico HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  126. Mexico HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  127. Rest of Latin America HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  128. Rest of Latin America HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  129. Rest of Latin America HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  130. Middle East & Africa HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  131. Middle East & Africa Consumables Market By Region, From2019-2024 ( USD Million )
  132. Middle East & Africa Instruments Market By Region, From2019-2024 ( USD Million )
  133. Middle East & Africa Software & Services Market By Region, From2019-2024 ( USD Million )
  134. Middle East & Africa HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  135. Middle East & Africa Antibody Tests Market By Region, From2019-2024 ( USD Million )
  136. Middle East & Africa Viral Identification tests Market By Region, From2019-2024 ( USD Million )
  137. Middle East & Africa CD4 Testing Market By Region, From2019-2024 ( USD Million )
  138. Middle East & Africa Viral Load Testing Market By Region, From2019-2024 ( USD Million )
  139. Middle East & Africa Early Infant Diagnosticss Market By Region, From2019-2024 ( USD Million )
  140. Middle East & Africa HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  141. Middle East & Africa Diagnostic Labortaries Market By Region, From2019-2024 ( USD Million )
  142. Middle East & Africa Hospitals Market By Region, From2019-2024 ( USD Million )
  143. Middle East & Africa Blood Banks Market By Region, From2019-2024 ( USD Million )
  144. Middle East & Africa Home Care Settings Market By Region, From2019-2024 ( USD Million )
  145. Middle East & Africa Other End Users Market By Region, From2019-2024 ( USD Million )
  146. Middle East HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  147. Middle East HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  148. Middle East HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )
  149. Africa HIV Diagnostics Market By Product, From2019-2024 ( USD Million )
  150. Africa HIV Diagnostics Market By Type, From2019-2024 ( USD Million )
  151. Africa HIV Diagnostics Market By End-User, From2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample